The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.50
Bid: 62.00
Ask: 65.00
Change: 1.00 (1.60%)
Spread: 3.00 (4.839%)
Open: 62.50
High: 63.50
Low: 62.50
Prev. Close: 62.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Valeura and Mast Energy losses widen; Altitude upbeat

Thu, 31st Mar 2022 21:06

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

City of London Group PLC - operates Recognise Bank for UK small and medium enterprises - After achieving full banking licence in September, lends GBP100 million to UK companies to date. In addition, Recognise Bank generates GBP95 million in deposits from personal savings customers.

----------

Toople PLC - Letchworth Garden City, England-based telecom services - During first quarter of current financial year, revenue increases 9%, allowing for a 17% increase in gross profit and 19% rise in earnings before interest, tax, depreciation and amortisation compared to the previous quarter. Trading momentum has passed on into the second quarter, translating into strong orders in March. Outlook from board is very positive, with expectations of a further increase in revenue and gross profit.

----------

Mast Energy Developments PLC - London-based developer of reserve power generations plants - For the 15 months ended December 31, pretax loss widens at GBP1.4 million from GBP657,564 the year before, as a sharp increase in expenses, both administrative and listing more than offset the generation of GBP3,245 in revenue from the company's first operating site at Pyebridge.

----------

Altitude Group PLC - Sheffield-based firm operating a marketplace for personalised products - For the year ending March 31, expects adjusted operating profit to rise 80% to around GBP1.0 million from GBP600,000, on revenue which is set to grow 56% to GBP12.0 million from GBP77.7 million. Also secures new 12-month working capital credit facility with TD Bank for USD700,000.

----------

Sancus Lending Group Ltd - Guernsey-based alternative property finance - For 2021, pretax loss narrows to GBP10.4 million from GBP14.5 million in 2020, in spite of a 17% decline in revenue to GBP9.0 million from GBP10.9 million, due to delays in loan completions triggered by the ongoing effect of Covid-19.

----------

Valeura Energy Inc - Canada-based company engaged in the exploration, development and production of petroleum and natural gas in Turkey - For 2021, net loss widens to USD64.3 million from USD20.2 million in 2020, mostly due to a charge of USD67.7 million, on the currency translation of subsidiaries liquidated and disposed of. In addition, revenue declined 63% to USD3.0 million from USD8.0 million, following a plunge in petroleum and gas sales.

----------

Harland & Wolff Group Holdings PLC - Belfast-based ship repair, conversion and offshore construction - For the 17 months ended December 31, expects to post gross revenue between GBP18 million and GBP20 million, following the securing of the company's first major fabrication contract with Saipem Ltd to manufacture eight wind turbine jacket structures, worth GBP26 million. Due to delays, most of the work will be fulfilled in 2022, meaning that part of the contract's revenue will be recognised in 2022. First quarter of 2022 is remarked being an "extremely busy period".

----------

Kazera Global PLC - diamonds and rare earths explorer in South Africa and Namibia - For the six months ended December 2021, pretax loss widens to GBP601,000 from GBP540,000 a year prior on higher administrative costs, more than offsetting the generation of GBP100,000 in revenue on diamond production. Looking ahead, Kazera is seeking to maximise production from its current assets while evaluating potential acquisition opportunities.

----------

Cambria Africa PLC - Zimbabwe-focused investment company - For 12 months to August 31, swings to pretax profit of USD276,000 from loss of USD424,000 prior year, on revenue of USD1.2 million, down 8% from USD1.3 million. Net asset value falls by 1.6% to USD6.32 million from USD6.42 million in financial 2020. Says the reduction in NAV was attributable in part to a USD200,000 downward adjustment in the valuation of its commercial property conducted by Hollands Harare Estate Agents.

----------

Marwyn Acquisition Co II Ltd - looking for make acquisition in sectors including media, technology and consumer e-commerce - For six months to December 31, pretax loss widens to GBP658,746 from GBP222,458 loss year before. "We believe there is significant opportunity to invest in businesses that have the potential to be long term beneficiaries of the changes to their respective sectors and the underlying acceleration of digitalisation that the current macro environment has brought about. We are active in pursuing and evaluating opportunities with advisers, potential management partners, and acquisition targets and are confident about acquiring an attractive platform business for our shareholders," it says. Marwyn Acquisition Co III Ltd books pretax loss of GBP519,323 for same period.

----------

Caledonian Trust PLC - Edinburgh-based property investment and development company - Posts net asset value as at December 31 of 206.7 pence, up from 201.7p at the same time year before. Interim pretax loss for the period narrows to GBP196,000 from GBP327,000 year before on revenue of GBP167,000, down sharply from GBP1.1 million.

----------

NetScientific PLC - London-based life sciences and sustainability technology investment firm - Notes portfolio company PDS Biotechnology Corp's annual results. For 2021, net loss was USD16.9 million, or USD0.66 per basic share and diluted share, compared to a net loss of USD14.8 million, or USD0.89 EPS in 2020. Ilian Iliev, CEO of NetScientific, says: "PDS has continued the steady progress and build-out of the business, progressing multiple clinical applications of the Versamune platform in immuno-oncology and infectious disease vaccines. The company's careful planning and successful fund-raise in 2021 - in which NetScientific participated - has positioned PDS well to weather market volatility, and continue to progress its clinical trials pipeline."

----------

Emmerson PLC - Khemisset potash project in northern Morocco - Says discussions over a financing package for the Khemisset potash project in Morocco have been supported by higher price of fertiliser due to the Russian invasion of Ukraine. "The importance of the Khemisset project as a new source of potash has risen significantly, and the board is more committed than ever to bring the mine into production as soon as possible. To that end, the company has made good progress in advancing the wide package of agreements relating to financing, offtake, equipment and consultants. The momentum in recent weeks has built noticeably across a number of fronts," it says.

----------

Active Energy Group PLC - London-based biomass focused renewable energy business - Says it enters into agreement to sell Lumberton site in North Carolina for USD4.7 million cash to US-based commercial real estate firm Phoenix Investors LLC.

----------

GYG PLC - Mallorca, Spain-based super-yacht painting, service and supply company - Says terms have been agreed on both of the Nobiskrug new build projects that were suspended in 2021. One of these projects will re-commence at the Nobiskrug shipyard and the second will be completed in another Northern European Shipyard representing a new opportunity. The works are scheduled to recommence on both projects in second quarter, it adds.

----------

Oxford Cannabinoid Technologies Holdings PLC - pharmaceutical company developing prescription cannabinoid medicines - Says it is making progress on its two lead cannabinoid medicines in pre-clinical development. Says OCT461201, which is being tested for both neuropathic and visceral pain, has seen "very encouraging" data, with successful reduction of pain in a model chemotherapy-induced peripheral neuropathy. As such, has decided to focus its strategy in neuropathic pain away from post-herpetic neuralgia and towards a clinical development programme aimed to benefit patients with small fibre neuropathies. For OCT130401, a drug-device combination delivering phytocannabinoids, the company intends to undertake phase one clinical trials in the fourth quarter of 2022 in healthy volunteers in Australia, where there is local experience in performing clinical trials with pCBs.

----------

WANdisco PLC - Sheffield-based data-management software company - Says it has signed a follow-on agreement worth USD1.2 million with existing telecommunications company, having announced an initial USD1.5 million commit-to-consume agreement earlier this month. The customer will use WANdisco's LiveData Migrator and LiveData Migrator for Azure to automate the migration of Hadoop data to AWS and Azure.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com and Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 May 2024 13:19

IN BRIEF: NetScientific says PDS Biotech's Versamune meets endpoints

NetScientific PLC - London-based deep tech and life sciences venture capital investor - Says its portfolio company, PDS Biotechnology Corp's Versamune meets endpoints in a phase three trial for patients with HPV. NetScientific holds a 3.5% shareholding in PDS. Versamune is a T cell-activating platform that effectively stimulates a precise immune system response to a cancer-specific protein.

Read more
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more
14 Aug 2023 19:49

IN BRIEF: NetScientific's PDS suffers wider loss as R&D costs mount

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Portfolio company PDS Biotechnology Corp reports results for the quarter to June 30. Net loss was USD11.5 million, widened from USD5.8 million the year before. Higher loss primarily due to costs incurred in connection with research and development programmes, which more than doubled to USD8.0 million from USD3.8 million. Loss per share of USD0.37 compared to USD0.20 before. Further, PDS reports the successful submission of final clinical protocol and supporting information to the US Food & Drug Administration to initiate phase 3 Versatile-003 trial in the fourth quarter. Adds biomarker data from Versatile-002 will be presented at the European Society for Medical Oncology Congress.

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Jun 2023 14:11

TRADING UPDATES: tinyBuild bemoans disappointing interim performance

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.